Related Experiment Video
Updated: May 23, 2026
09:10
Palatable Western-style Cafeteria Diet as a Reliable Method for Modeling Diet-induced Obesity in Rodents
Published on: November 1, 2019
[Micronutrient consumption and overweight: is there a relationship?]
Ana Luisa Marcucci Leão1, Luana Caroline dos Santos
1Grupo de Pesquisa em Intervenções em Nutrição, Universidade Federal de Minas Gerais, Belo Horizonte.
Summary
Micronutrient deficiency impacts global health, increasing non-communicable disease risk, including obesity. Addressing dietary micronutrient intake is crucial for public health strategies and obesity control.
Area of Science:
- Nutrition Science
- Public Health
- Metabolic Health
Context:
- Rising global obesity rates linked to lifestyle changes and dietary shifts.
- Micronutrient intake is a critical, often overlooked, factor in population health.
- Understanding micronutrient roles is essential for public health interventions.
Purpose:
- To review the impact of micronutrient intake on nutritional status.
- To describe the consequences of micronutrient deficiencies and excesses.
- To inform strategies for obesity prevention and management.
Summary:
- Micronutrient deficiency affects 2 billion people globally, increasing non-communicable disease risk.
- Specific vitamins (A, C, D) and minerals (calcium, zinc) play key roles in metabolism, fat oxidation, satiety, and hormonal regulation relevant to obesity.
- Insufficient intake of these micronutrients is associated with overweight and obesity.
Impact:
- Highlights the critical role of micronutrients in metabolic health and obesity.
- Underscores the need for public health initiatives promoting healthy eating habits and micronutrient awareness.
- Provides evidence for integrating nutritional status monitoring into obesity control strategies.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:19Energy Balance
The human body gets energy from the three macronutrients: carbohydrates, proteins, and fats. Energy is released when the chemical bonds in the organic compounds present in the food are broken down. The energy content of food is measured in kilocalories (kcal), defined as the amount of heat required to raise the temperature of one kilogram of water by one degree Celsius. This value is determined by measuring the temperature change of the water surrounding a calorimeter after the complete...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:28Microbial Nutrition
Organisms exhibit remarkable metabolic diversity, categorized based on how they acquire energy and carbon. These strategies enable survival in various ecological niches and are essential for maintaining energy flow and nutrient cycling within ecosystems.Energy and Carbon SourcesOrganisms are classified as phototrophs or chemotrophs based on energy acquisition. Phototrophs use light as their energy source, while chemotrophs rely on oxidizing chemical compounds. Further differentiation arises...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...